Psychedelic-Enhanced Therapy Business For Sale

PricewaterhouseCoopers Inc., LIT (“PwC”), in its capacity as the Court-appointed monitor (the “Monitor”) of:

Field Trip Health & Wellness Ltd., Field Trip Health Holdings Inc., Field Trip Health Canada Inc., Field Trip Digital Canada Inc., and Field Trip Health USA Inc. (collectively, “Field Trip” or the “Company”)

is launching a Court-approved sale and investment solicitation process (“SISP”) for the purpose of soliciting proposals to purchase or invest in some or all of Field Trip’s assets, business and operations. Field Trip is a leader in the development and delivery of psychedelic-enhanced therapies. The Company currently operates four clinics across Canada (Toronto, Vancouver) and the United States (New York, Santa Monica).

In order to obtain detailed information on Field Trip, interested parties will be required to sign a non-disclosure agreement. The deadline for submitting a binding offer is April 24, 2023 at 5:00 p.m. ET.

For further information, please refer to www.pwc.com/ca/fieldtrip or contact at ca_fieldtrip@pwc.com.

PricewaterhouseCoopers Inc., LIT
Monitor of Field Trip Health & Wellness Ltd., Field Trip Health Holdings Inc.,
Field Trip Health Canada Inc., Field Trip Digital Canada Inc., and Field Trip Health USA Inc.
18 York Street, Suite 2600
Toronto, ON M5J 0B2
Email: ca_fieldtrip@pwc.com